Accelerated Enrollment
Multi-Level Screening
Lagging Recruitment: Shingles affects millions, and effective treatment options are vital. But precise targeting is needed to find patients who are at risk and also fit within what are typically strict I/E criteria. 1nHealth partnered with a sponsor for a new Phase 2 on US site-based Phase 2 shingles vaccine study running in 11 sites across the United States. Recruitment had fallen behind, so 1nHealth was engaged to supplement site recruitment efforts to close Phase 2 within the enrollment window.
Data-Driven Enrollment: A/B testing top-of-funnel ad sets allows for identifying the most effective messaging and targeting, ensuring the right candidates are being reached from the start. By optimizing these ads, you reduce the likelihood of attracting unqualified participants, which directly lowers screen fail rates mid-funnel. This iterative approach improves lead quality and streamlines the recruitment process, helping clinical trials enroll more eligible participants and keep the study on track.
Hands-On Support: Our operations team provided hands-on support directly to each site’s staff to ensure online-generated potential patients were qualified and scheduled seamlessly. This included deploying 1nData as the study’s all-in-one patient tracking platform—giving site staff and sponsor teams access to real-time patient data, site-by-site comparison metrics, and automated follow-up communication.
Back On Track: Before 1nHealth was involved in the study, sites were only seeing 26 ICFs per week. After we started to supplement the enrollment efforts, that average jumped to 61 ICFs per week. Not only did our efforts accelerate enrollment, but the study was completed a full month before sponsor’s original pre-1nHealth expected timeline.
